| Sanofi-Aventis (Suisse) SA - Pentavac, Poudre et suspension pour suspension injectable | | 00613 | | 01 | | Pentavac | | Poudre et suspension pour suspension injectable | | J07CA06 | | Diphtherie-Haemophilus-influenzae B-Pertussis-Poliomyelitis-Tetanus | | 18.08.1999 | | |
| | Zusammensetzung | | I) composant DPTa-IPV (suspension): toxoidum diphtheriae min. 20 U.I., toxoidum tetani min. 40 U.I., bordetellae pertussis antigenum: toxoidum pertussis 25 µg et haemagglutininum filamentosum 25 µg, virus poliomyelitis typus 1 inactivatus 29 U., virus poliomyelitis typus 2 inactivatus 7 U., virus poliomyelitis typus 3 inactivatus 26 U., aluminium 0.3 mg ut aluminii hydroxidum hydricum ad adsorptionem, formaldehydum, medium 199 cum phenylalaninum 12.5 µg et kalium, acidum aceticum glaciale q.s. ad pH, natrii hydroxidum q.s. ad pH, phenoxyethanolum, ethanolum anhydricum 2 mg, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml, residui: neomycinum, streptomycinum, polymyxinum B nihil.
II) composant Hib (poudre): polysaccharida haemophili influenzae typus B 1482 conjugata cum toxoido tetani 10 µg, trometamolum, saccharum, acidum hydrochloridum q.s. ad pH, pro praeparatione. | | Packungsbestandteile | | II | | | suspension injectable et lyophilisat | | | | | | | | | BAG: Wirkstoffe | Stärke |
|---|
| Haemophilus Influenzae b Polysaccharida (Prp) | 10 mcg | | Toxoidum Diphtheriae | 20 UI | | Toxoidum Pertussis | 25 mcg | | Toxoidum Tetani | 40 UI | | Vaccinum Poliomyelitidis Inactivatum (Salk typ I, II, III) | 62 U |
| | | | Hilfsstoffe | Stärke |
|---|
| Acidum Hydrochloridum | | | Composant hib (Poudre): Polysaccharida Haemophili Influenzae Typus B | 1482 | | Conjugata cum Toxoido Tetani | 10 µg | | Saccharum | | | Trometamolum | |
| |
| I | | | Poudre et suspension pour suspension injectable | | | | | | | | Wirkstoffe | Stärke |
|---|
| Composant Dpta-Ipv (Suspension): Toxoidum Diphtheriae | 20 UI | | Toxoidum Tetani | 40 UI |
| | BAG: Wirkstoffe | Stärke |
|---|
| Haemophilus Influenzae b Polysaccharida (Prp) | 10 mcg | | Toxoidum Diphtheriae | 20 UI | | Toxoidum Pertussis | 25 mcg | | Toxoidum Tetani | 40 UI | | Vaccinum Poliomyelitidis Inactivatum (Salk typ I, II, III) | 62 U |
| | | | Hilfsstoffe | Stärke | Zusätzliche Information |
|---|
| Acidum Aceticum Glaciale | | | | Aluminium | 0.3 mg | | | Cum Phenylalaninum | 12.5 µg | | | Formaldehydum | | | | Haemagglutininum Filamentosum | 25 µg | | | Inactivatus | 26 U | | | Kalium | | | | Medium | 199 | | | Toxoidum Pertussis | 25 µg | bordetellae pertussis antigenum | | Virus Poliomyelitis Typus | 3 | |
| |
| | Packungsnummer | Packungsgrösse | EFP | PP | Kat. | SL | In Refdata nicht gelistet |
|---|
| 001 | Durchstechflasche(n) | 34.19 | 53.60 | B | SL | Ja |
|
|
